Cargando…

Hepatitis B and pertussis antibodies in 4- to 5-year-old children previously vaccinated with different hexavalent vaccines

In randomized active-comparator controlled studies, DTaP5-HB-IPV-Hib showed comparable immunogenicity and safety to other licensed vaccines. This study assessed persistence of anti-hepatitis B surface antigen (HBs) and anti-pertussis antibodies, when children were 4 to 5 years of age, 3 to 4 years a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vesikari, Timo, Xu, Jin, Johnson, David R., Hall, Jessie, Marček, Tomáš, Goveia, Michelle G., Acosta, Camilo J., Lee, Andrew Wen-Tseng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227712/ https://www.ncbi.nlm.nih.gov/pubmed/31689166 http://dx.doi.org/10.1080/21645515.2019.1673119

Ejemplares similares

Demonstration of durable hepatitis B immune memory in children vaccinated with a DTaP5-IPV-HepB-Hib infant-toddler series 7 to 8 years previously
por: Ahonen, Anitta, et al.
Publicado: (2022)

Infant vaccination against pertussis in Argentina: Parent-reported outcomes on reactogenicity, impact on daily routine and satisfaction after pentavalent whole-cell or hexavalent acellular pertussis vaccines
por: Gentile, Angela, et al.
Publicado: (2023)

Pertussis-Associated Persistent Cough in Previously Vaccinated Children
por: Principi, Nicola, et al.
Publicado: (2017)

Lasting immune memory against hepatitis B in 12–13-year-old adolescents previously vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy
por: Behre, Ulrich, et al.
Publicado: (2016)

Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age
por: Silfverdal, Sven A, et al.
Publicado: (2014)

Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection
por: Knuutila, Aapo, et al.
Publicado: (2023)

153. The Effect of Timing of Tetanus–Diphtheria and Pertussis Vaccine Administration in Pregnancy on The Avidity of Pertussis Antibodies
por: Raya, Bahaa Abu, et al.
Publicado: (2018)

Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa
por: Vesikari, Timo, et al.
Publicado: (2017)

The Effect of Timing of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administration in Pregnancy on the Avidity of Pertussis Antibodies
por: Abu-Raya, Bahaa, et al.
Publicado: (2019)

Pertussis Vaccine in COPD and Asthma: An Old Acquaintance Is Back
por: Villar-Álvarez, Felipe, et al.
Publicado: (2021)

Vaccination and Pertussis
por: Fink, Lawrence G.
Publicado: (1908)

Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b vaccine; Infanrix™ hexa: Twelve years of experience in Italy
por: Baldo, Vincenzo, et al.
Publicado: (2014)

Prior exposure to B. pertussis shapes the mucosal antibody response to acellular pertussis booster vaccination
por: van Schuppen, Evi, et al.
Publicado: (2022)

Kawasaki disease in an infant after administration of hexavalent vaccine
por: Almeshary, Meshal Z., et al.
Publicado: (2021)

Cost minimization analysis of a hexavalent vaccine in Argentina
por: Olivera, Ignacio, et al.
Publicado: (2023)

Trimeric S protein COVID-19 vaccine needs to find its place
por: Vesikari, Timo
Publicado: (2022)

Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States
por: Klein, Nicola P., et al.
Publicado: (2019)

Antibody persistence in pre-school children after hexavalent vaccine infant primary and booster administration
por: Madhi, Shabir A., et al.
Publicado: (2019)

mSphere of Influence: Pertussis Vaccination and Antibodies in Mothers and Infants
por: Portillo, Susana
Publicado: (2023)

Acellular Pertussis Vaccines and Pertussis Resurgence: Revise or Replace?
por: Ausiello, Clara Maria, et al.
Publicado: (2014)

Pertussis Toxin: A Key Component in Pertussis Vaccines?
por: Gregg, Kelsey A., et al.
Publicado: (2019)

The effect of maternal pertussis vaccination on the epidemiology of pertussis in Spain
por: Godoy, Pere, et al.
Publicado: (2022)

The effect of maternal pertussis vaccination on the epidemiology of pertussis in Spain
por: Godoy, Pere, et al.
Publicado: (2022)

Evaluation of the Potency of the Pertussis Vaccine in Experimental Infection Model with Bordetella pertussis: Study of the Case of the Pertussis Vaccine Used in the Expanded Vaccination Program in Algeria
por: Tahar djebbar, Khedidja, et al.
Publicado: (2022)

161. impact of State Childcare and School Hepatitis a Vaccination Requirements on Coverage of Hepatitis a Vaccines in the United States
por: Choi, Yoonyoung, et al.
Publicado: (2020)

Structure and compositional analysis of aluminum oxyhydroxide adsorbed pertussis vaccine
por: Duprez, Jessica, et al.
Publicado: (2020)

Efficacy, safety and immunogenicity of hexavalent rotavirus vaccine in Chinese infants
por: Wu, Zhiwei, et al.
Publicado: (2022)

What are the preferences of health care professionals in Germany regarding fully liquid, ready-to-use hexavalent pediatric vaccine versus hexavalent pediatric vaccine that needs reconstitution?
por: Lloyd, Andrew J, et al.
Publicado: (2015)

Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents
por: Vesikari, Timo, et al.
Publicado: (2016)

Antibody Specificity Following a Recent Bordetella pertussis Infection in Adolescence Is Correlated With the Pertussis Vaccine Received in Childhood
por: Raeven, René H. M., et al.
Publicado: (2019)

Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines
por: Markey, Kevin, et al.
Publicado: (2019)

Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish children
por: von Linstow, Marie-Louise, et al.
Publicado: (2010)

Immunoproteomic Analysis of Human Serological Antibody Responses to Vaccination with Whole-Cell Pertussis Vaccine (WCV)
por: Zhu, Yong-Zhang, et al.
Publicado: (2010)

Estimating the Total Societal Cost of a Hexavalent Vaccine versus a Pentavalent Vaccine with Hepatitis B in South Korea
por: Min, Serim, et al.
Publicado: (2023)

The Effect of Maternal Pertussis Immunization on Infant Vaccine Responses to a Booster Pertussis-Containing Vaccine in Vietnam
por: Maertens, Kirsten, et al.
Publicado: (2016)

Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines
por: Esposito, Susanna, et al.
Publicado: (2019)

Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis
por: Ma, Longhuan, et al.
Publicado: (2021)

Association Between State Hepatitis A Vaccination Requirements and Hepatitis A Vaccination Rates
por: Choi, Yoonyoung, et al.
Publicado: (2022)

A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines
por: Giambi, Cristina, et al.
Publicado: (2008)

Estimating the Effectiveness of Tetanus-Diphtheria-Acellular Pertussis Vaccine
por: Decker, Michael D., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jtl133dq01tdcda7cgo6fdeak2